YYsios Capital
Ysios Capital is a leading Spanish venture capital firm founded in 2008 that finances innovative biotechnology, medical device, and life sciences companies developing novel therapies for unmet medical needs, from early stages through clinical development. It manages over €400 million across multiple funds (including the newly launched €100M InceptionBio fund for biotech company creation) and has backed 42 portfolio companies, with 19 products reaching market and 70+ in clinical development.
SectorsBiotechnology, Medical devices, Gene therapy, Cell therapy, Oncology, Rare diseases
VC MapSeries B
Team
Joël Jean-Mairet
Managing Partner
Julia Salaverría
Managing Partner
Karen Wagner
Managing Partner
Joan Perelló
Managing Partner
Jordi Xiol
Partner
Guillem Laporta
Partner
Arturo Urrios
Partner
David L. Lacey
Venture Partner
Antoni Ribas
Venture Partner
Pamela Klein
Venture Partner
Carlos Garcia-Echeverria
Venture Partner
Lance Berman
Venture Partner
Carlos Paya
Venture Partner
Portfolio companies 8
Open 7 as list → On map →
AAnaconda Biomed
led Series A, 2017
OOna Therapeutics
entered at Series A, 2020
SSpliceBio
led Series A, 2022
MMinoryx Therapeutics
led Series A, 2015
AAELIX Therapeutics
led Series A, 2016
M
Medlumics
led Series A, 2011
IInbiomotion
led Series A, 2012
Exited or sunsetted (1)
SSanifit
per company site